Taletrectinib US FDA Label
- Compound: 3-[4-[(2R)-2-aminopropoxy]phenyl]-N-[(1R)-1-(3-fluorophenyl)ethyl]imidazo[1,2-b]pyridazin-6-amine
- Description: Taletrectinib is an orally available small molecule kinase inhibitor. It is targeted against ROS1, including resistant mutant forms, and shows some inhibitor activity against tropomyosin receptor kinases (TRKs) TRKA, TRKB, and TRKC.
- Brand Name:
- Code(s): AB106
- Approved:
- Kinase Class: RY
- Inhibitor Type: ?
- Literature (PubMed): 0
- Target(s): epidermal growth factor receptor
- Disease(s): non-small-cell lung carcinoma